US Bancorp
RKDA icon

US Bancorp’s Arcadia Biosciences RKDA Stock Holding History

US Bancorp’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5
Closed -$14 – 4248
2024
Q3 		$14 Hold
5
– – ﹤0.01% 4063
2024
Q2 		$16 Hold
5
– – ﹤0.01% 3956
2024
Q1 		$11 Hold
5
– – ﹤0.01% 3949
2023
Q4 		$16 Hold
5
– – ﹤0.01% 3945
2023
Q3 		$17 Hold
5
– – ﹤0.01% 3965
2023
Q2 		$19 Hold
5
– – ﹤0.01% 3969
2023
Q1 		$37 Buy
+5
New +$53 ﹤0.01% 4059

Other funds holding RKDA

Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWM
Atticus Wealth Management Palm Beach Gardens, Florida $420M AUM 23.31% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

US Bancorp's RKDA Position: Q4 2024 in Review

US Bancorp sold out of Arcadia Biosciences (RKDA) in Q4 2024, closing a stake of 5 shares — an estimated $14 sold.

US Bancorp first reported a position in RKDA in Q1 2023 and held it in 7 quarters. The position peaked at $37 in Q1 2023. 13 funds tracked by Wall St. Rank hold RKDA as of Q4 2024.

  • US Bancorp reported no remaining Arcadia Biosciences position as of Q4 2024 after selling out during the quarter.
  • US Bancorp sold 5 Arcadia Biosciences shares in Q4 2024, an estimated $14.
  • US Bancorp first reported a position in Arcadia Biosciences in Q1 2023 and held it in 7 quarters.
  • US Bancorp's Arcadia Biosciences position peaked at $37 in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2024.

Based on US Bancorp's 13F filing for Q4 2024, filed 5 Feb 2025.